J. Sorensen
Vorstandsvorsitzender bei GALERA THERAPEUTICS, INC.
Vermögen: 71 389 $ am 31.05.2024
Aktive Positionen von J. Sorensen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GALERA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.11.2012 | - |
Vorstandsvorsitzender | 01.11.2012 | - | |
Präsident | 01.11.2012 | - | |
Oncopia Therapeutics, Inc.
Oncopia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Oncopia Therapeutics LLC engages in biotechnology research. The company was founded in 2017 and is headquartered in Malvern, PA. | Direktor/Vorstandsmitglied | - | - |
Esanik Therapeutics, Inc.
Esanik Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Esanik Therapeutics, Inc. develops treatments for cancer. | Direktor/Vorstandsmitglied | - | - |
Medsyn Biopharma LLC
Medsyn Biopharma LLC BiotechnologyHealth Technology Medsyn Biopharma LLC develops therapeutics for cancer. The company was founded by Shaomeng Wang and is headquartered in Malvern, PA. | Direktor/Vorstandsmitglied | - | - |
PlanetVerify Ltd.
PlanetVerify Ltd. Packaged SoftwareTechnology Services PlanetVerify Ltd. provides electronic monetary transactions services. The company was founded by Owen Sorensen, Farmar Sean, and Heather Kennedy in 2013 and is headquartered in Dublin, Ireland. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von J. Sorensen
Ehemalige bekannte Positionen von J. Sorensen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Direktor/Vorstandsmitglied | - | 22.03.2021 |
Oncofusion Therapeutics, Inc.
Oncofusion Therapeutics, Inc. BiotechnologyHealth Technology Oncofusion Therapeutics, Inc. operates as oncology development company. It specializes in BET Bromodomain Inhibitors, ERG Inhibitors, EZH2-EED Inhibitors and MMSET/NSD2 Inhibitors. The company was founded in 2012 by Arul M. Chinnaiyan and Shaomeng Wang and is headquartered in Ann Arbor, MI. | Vorsitzender | - | 01.01.2018 |
LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Direktor/Vorstandsmitglied | 07.10.2008 | 16.04.2014 |
Ascenta Therapeutics, Inc.
Ascenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA. | Vorstandsvorsitzender | 01.08.2004 | 01.01.2012 |
Präsident | 01.08.2004 | 01.01.2012 | |
░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von J. Sorensen
University College Dublin | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 12 |
Irland | 3 |
China | 3 |
Operativ
Director/Board Member | 8 |
Corporate Officer/Principal | 3 |
Chairman | 3 |
Sektoral
Health Technology | 11 |
Commercial Services | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GALERA THERAPEUTICS, INC. | Health Technology |
LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Health Technology |
Private Unternehmen | 13 |
---|---|
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Health Technology |
Oncofusion Therapeutics, Inc.
Oncofusion Therapeutics, Inc. BiotechnologyHealth Technology Oncofusion Therapeutics, Inc. operates as oncology development company. It specializes in BET Bromodomain Inhibitors, ERG Inhibitors, EZH2-EED Inhibitors and MMSET/NSD2 Inhibitors. The company was founded in 2012 by Arul M. Chinnaiyan and Shaomeng Wang and is headquartered in Ann Arbor, MI. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
Ascenta Therapeutics, Inc.
Ascenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
Therasis, Inc.
Therasis, Inc. Pharmaceuticals: MajorHealth Technology Therasis, Inc. develops oncology drugs. It offers oncology therapeutics for use as single agents or in combination therapy. The firm's proprietary technology, the Therasis Filter, represents a paradigm shift in the ability to discover therapeutic targets, their chemical inhibitors, and associated biomarkers and this platform integrates world-class expertise in high throughput screening, systems biology, cancer genetics and clinical research. The company was founded by Owen A. O'Connor and Riccardo Dalla-Favera in 2007 and is headquartered in New York, NY. | Health Technology |
Ascentage Shanghai Pharmaceutical Co., Ltd. | |
Jiangsu Yasheng Pharmaceutical Development Co. Ltd.
Jiangsu Yasheng Pharmaceutical Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Jiangsu Yasheng Pharmaceutical Development Co. Ltd. develops and produces pharmaceutical products. It focuses on research and development of structure-based molecule for cancer drugs. The company was founded by Dajun Yang, Ming Guo, and Shaomeng Wang in 2009 and is headquartered in Hong Kong. | Health Technology |
PlanetVerify Ltd.
PlanetVerify Ltd. Packaged SoftwareTechnology Services PlanetVerify Ltd. provides electronic monetary transactions services. The company was founded by Owen Sorensen, Farmar Sean, and Heather Kennedy in 2013 and is headquartered in Dublin, Ireland. | Technology Services |
Oncopia Therapeutics, Inc.
Oncopia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Oncopia Therapeutics LLC engages in biotechnology research. The company was founded in 2017 and is headquartered in Malvern, PA. | Commercial Services |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Health Technology |
Esanik Therapeutics, Inc.
Esanik Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Esanik Therapeutics, Inc. develops treatments for cancer. | Commercial Services |
Medsyn Biopharma LLC
Medsyn Biopharma LLC BiotechnologyHealth Technology Medsyn Biopharma LLC develops therapeutics for cancer. The company was founded by Shaomeng Wang and is headquartered in Malvern, PA. | Health Technology |
- Börse
- Insiders
- J. Sorensen
- Erfahrung